Profile picture

Doctor Giuseppe Ammirati

AOU Federico II University of Naples, Naples (Italy)
Follow
Biography
Dr. Giuseppe Ammirati is a cardiologist specializing in cardiac electrophysiology at the Federico II University Hospital in Naples. He joined the Cardiovascular Pathophysiology and Therapeutics (CardioPaTh) PhD program at the University of Naples Federico II, focusing on translational research in arrhythmia mechanisms, heart failure, and device-based therapies. Dr. Ammirati completed a clinical fellowship at Montefiore Medical Center in New York under the mentorship of Prof Luigi Di Biase. His professional expertise includes atrial fibrillation ablation, left atrial appendage occlusion, cardiac resynchronization therapy, conduction system pacing, and device extraction in endocarditis settings. His current research interests encompass advanced mapping and ablation techniques, neuromodulation in refractory arrhythmias, and novel interventional strategies for stroke prevention. Dr. Ammirati has authored and co-authored several peer-reviewed publications.
Logo ESC

Contributor content

Atrial fibrillation ablation using three-dimensional artificial intelligence module integration with intracardiac echocardiography
Journal
Atrial fibrillation ablation using three-dimensional artificial intelligence module integration with intracardiac echocardiography
16 January 2026
Application repetition and electrode–tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter
Journal
Application repetition and electrode–tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter
16 August 2024
A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy
Journal
A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy
24 May 2024
Impact of taurolidine use during cardiac electronic implantable device implantation in heart failure patients
Journal
Impact of taurolidine use during cardiac electronic implantable device implantation in heart failure patients
24 May 2024